Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.03 is 10% below its 5-year average of 1.15, near the low end of its 5-year range (0.95–1.71).
As of the fiscal period ended Tuesday, June 30, 2026. 24.80% below its 12-month average of 1.37.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.03.
CURRENT RATIO
1.03
CURRENT RATIO AVG TTM
1.37
CURRENT RATIO AVG 3Y
1.13
CURRENT RATIO AVG 5Y
1.15
CURRENT RATIO AVG 10Y
1.14
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.80%
CURRENT VS 3Y AVG
-8.87%
CURRENT VS 5Y AVG
-10.41%
CURRENT VS 10Y AVG
-9.79%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 636 covered companies
CURRENT VS SECTOR MEDIAN
-69.64%
vs the sector median at left
Collegium Pharmaceutical, Inc.
Market Cap
$708.19M
Current Ratio
1.03
TTM Avg
1.37
3Y Avg
1.13
5Y Avg
1.15
Market Cap
$707.95M
Current Ratio
8.86
TTM Avg
10.22
3Y Avg
11.35
5Y Avg
25.38
Market Cap
$692.29M
Current Ratio
14.20
TTM Avg
2.62
3Y Avg
2.46
5Y Avg
2.12
Market Cap
$718.57M
Current Ratio
19.31
TTM Avg
14.05
3Y Avg
7.67
5Y Avg
5.91
Market Cap
$704.02M
Current Ratio
19.69
TTM Avg
6.38
3Y Avg
9.16
5Y Avg
11.87
Market Cap
$716.10M
Current Ratio
4.48
TTM Avg
5.45
3Y Avg
6.78
5Y Avg
8.00
Market Cap
$731.45M
Current Ratio
0.95
TTM Avg
4.92
3Y Avg
2.98
5Y Avg
5.72
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | $708.19M | 1.03 | 1.37 | 1.13 | 1.15 |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $707.95M | 8.86 | 10.22 | 11.35 | 25.38 |
| Anteris Technologies Global Corp. (AVR)vs › | $692.29M | 14.20 | 2.62 | 2.46 | 2.12 |
| Avalo Therapeutics, Inc. (AVTX)vs › | $718.57M | 19.31 | 14.05 | 7.67 | 5.91 |
| Faeth Therapeutics, Inc. (FTH)vs › | $704.02M | 19.69 | 6.38 | 9.16 | 11.87 |
| Cytek Biosciences, Inc. (CTKB)vs › | $716.10M | 4.48 | 5.45 | 6.78 | 8.00 |
| Achieve Life Sciences, Inc. (ACHV)vs › | $731.45M | 0.95 | 4.92 | 2.98 | 5.72 |
| Annexon, Inc. (ANNX)vs › | $676.72M | 5.53 | 8.02 | 10.47 | 14.43 |
| MiMedx Group, Inc. (MDXG)vs › | $665.40M | 5.33 | 4.27 | 3.79 | 3.57 |
| Helus Pharma Inc. (HELP)vs › | $666.95M | 10.97 | 8.63 | 10.75 | 10.66 |
Current Ratio
1.03
Quick Ratio
0.84
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.03 |
| 2026-03-31 | 1.71 |
| 2025-12-31 | 1.57 |
| 2025-09-30 | 1.36 |
| 2025-06-30 | 1.18 |
| 2025-03-31 | 1.08 |
| 2024-12-31 | 0.95 |
| 2024-09-30 | 0.97 |
| 2024-06-30 | 1.11 |
| 2024-03-31 | 1.21 |
| 2023-12-31 | 1.17 |
| 2023-09-30 | 1.16 |
| 2023-06-30 | 1.24 |
| 2023-03-31 | 1.21 |
| 2022-12-31 | 0.97 |
| 2022-09-30 | 0.98 |
| 2022-06-30 | 0.99 |
| 2022-03-31 | 0.97 |
| 2021-12-31 | 1.13 |
| 2021-09-30 | 1.35 |
| 2021-06-30 | 1.40 |
| 2021-03-31 | 1.29 |
| 2020-12-31 | 1.16 |
| 2020-09-30 | 1.08 |
| 2020-06-30 | 0.99 |
| 2020-03-31 | 0.92 |
| 2019-12-31 | 1.27 |
| 2019-09-30 | 1.24 |
| 2019-06-30 | 1.25 |
| 2019-03-31 | 1.24 |
| 2018-12-31 | 1.27 |
| 2018-09-30 | 0.78 |
| 2018-06-30 | 0.82 |
| 2018-03-31 | 0.83 |
| 2017-12-31 | 4.24 |
| 2017-09-30 | 4.50 |
| 2017-06-30 | 4.22 |
| 2017-03-31 | 5.56 |
| 2016-12-31 | 6.92 |
| 2016-09-30 | 4.29 |
| 2016-06-30 | 6.40 |
| 2016-03-31 | 12.25 |
| 2015-12-31 | 16.81 |
| 2015-09-30 | 12.36 |
| 2015-06-30 | 18.36 |
| 2015-03-31 | 6.98 |
| 2014-12-31 | 0.43 |
| 2014-09-30 | 0.00 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
